PT Etana Biotechnologies Indonesia has officially introduced two new cancer treatment drugs—Etapidi (tislelizumab) and Brukinsa (zanubrutinib)—marking a significant milestone in the country’s healthcare landscape. The
Author: Colleen Wilson
Okeiro Raises €10 Million to Expand AI-Driven Precision Medicine Platform for Transplantation and Chronic Diseases
Okeiro, a French company specializing in precision medicine for transplantation and advanced chronic diseases, has announced a €10 million funding round to support its growth
Hyundai Insteroid: A Video Game Dream on Wheels
Hyundai has unveiled a bold new design concept called the Insteroid, transforming its modest compact EV, the Inster, into a futuristic fusion of race car